Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $11 | $14 | $23 | $63 |
| - Cash | $27 | $32 | $28 | $40 |
| + Debt | $3 | $5 | $2 | $0 |
| Enterprise Value | -$13 | -$12 | -$3 | $22 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$9 | -$7 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$13 | -$24 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.54 | -1.09 | -2.05 | -0.45 |
| % Growth | 50.5% | 46.8% | -355.6% | – |
| Operating Cash Flow | -$4 | -$4 | -$8 | -$11 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$4 | -$9 | -$11 |